PAULO JENG CHIAN SUEN

(Fonte: Lattes)
Índice h a partir de 2011
8
Projetos de Pesquisa
Unidades Organizacionais
LIM/27 - Laboratório de Neurociências, Hospital das Clínicas, Faculdade de Medicina

Resultados de Busca

Agora exibindo 1 - 6 de 6
  • article 3 Citação(ões) na Scopus
    Trajectories of common mental disorders symptoms before and during the COVID-19 pandemic: findings from the ELSA-Brasil COVID-19 Mental Health Cohort
    (2022) FATORI, Daniel; SUEN, Paulo; BACCHI, Pedro; AFONSO, Leonardo; KLEIN, Izio; CAVENDISH, Beatriz A.; LEE, Younga H.; LIU, Zhaowen; BAUERMEISTER, Joshua; MORENO, Marina L.; VIANA, Maria Carmen; GOULART, Alessandra C.; SANTOS, Itamar S.; BAUERMEISTER, Sarah; SMOLLER, Jordan; LOTUFO, Paulo; BENSENOR, Isabela M.; BRUNONI, Andre R.
    Aim Evidence indicates most people were resilient to the impact of the COVID-19 pandemic on mental health. However, evidence also suggests the pandemic effect on mental health may be heterogeneous. Therefore, we aimed to identify groups of trajectories of common mental disorders' (CMD) symptoms assessed before (2017-19) and during the COVID-19 pandemic (2020-2021), and to investigate predictors of trajectories. Methods We assessed 2,705 participants of the ELSA-Brasil COVID-19 Mental Health Cohort study who reported Clinical Interview Scheduled-Revised (CIS-R) data in 2017-19 and Depression Anxiety Stress Scale-21 (DASS-21) data in May-July 2020, July-September 2020, October-December 2020, and April-June 2021. We used an equi-percentile approach to link the CIS-R total score in 2017-19 with the DASS-21 total score. Group-based trajectory modeling was used to identify CMD trajectories and adjusted multinomial logistic regression was used to investigate predictors of trajectories. Results Six groups of CMD symptoms trajectories were identified: low symptoms (17.6%), low-decreasing symptoms (13.7%), low-increasing symptoms (23.9%), moderate-decreasing symptoms (16.8%), low-increasing symptoms (23.3%), severe-decreasing symptoms (4.7%). The severe-decreasing trajectory was characterized by age < 60 years, female sex, low family income, sedentary behavior, previous mental disorders, and the experience of adverse events in life. Limitations Pre-pandemic characteristics were associated with lack of response to assessments. Our occupational cohort sample is not representative. Conclusion More than half of the sample presented low levels of CMD symptoms. Predictors of trajectories could be used to detect individuals at-risk for presenting CMD symptoms in the context of global adverse events.
  • article 0 Citação(ões) na Scopus
    Drug use among medical students in São Paulo, Brazil: a cross-sectional study during the coronavirus disease 2019 pandemic
    (2024) LEMOS-SANTOS, Pedro; BLUMRICH, Lukas; DEBIA, Jordi Blanes; CASTALDELLI-MAIA, Joao Mauricio; SUEN, Paulo Jeng Chian; MALBERGIER, Andre
    BACKGROUND: Medical students demonstrate higher rates of substance use than other university students and the general population. The challenges imposed by the coronavirus disease 2019 (COVID-19) pandemic raised significant concerns about mental health and substance use.OBJECTIVES: Assess the current prevalence of substance use among medical students at the University of Sao Paulo and evaluate the impact of the COVID-19 pandemic on drug consumption.DESIGN AND SETTING: A cross-sectional study was conducted on 275 medical students from the UniverMETHODS: Substance use (lifetime, previous 12 months, and frequency of use before and during the COVID-19 pandemic) and socioeconomic data were assessed using an online self-administered questionnaire. Symptoms of depression were assessed using the Patient Health Questionnaire-9. RESULTS: Alcohol was the most consumed substance in their lifetime (95.6%), followed by illicit drugs (61.1%), marijuana (60%), and tobacco (57.5%). The most commonly consumed substances in the previous year were alcohol (82.9%), illicit drugs (44.7%), marijuana (42.5%), and tobacco (36%). Students in the first two academic years consumed fewer substances than those from higher years. There was a decreasing trend in the prevalence of most substances used after the COVID-19 pandemic among sporadic users. However, frequent users maintained their drug use patterns.CONCLUSION: The prevalence of substance use was high in this population and increased from the basic to the clinical cycle. The COVID-19 pandemic may have affected the frequency of drug use and prevalence estimates.
  • article 2 Citação(ões) na Scopus
    Treatment of depression in the elderly with repetitive transcranial magnetic stimulation using theta-burst stimulation: Study protocol for a randomized, double-blind, controlled trial
    (2022) VALIENGO, Leandro; PINTO, Bianca S.; MARINHO, Kalian A. P.; SANTOS, Leonardo A.; TORT, Luara C.; BENATTI, Rafael G.; TEIXEIRA, Bruna B.; MIRANDA, Cristiane S.; CARDEAL, Henriette B.; SUEN, Paulo J. C.; LOUREIRO, Julia C.; VAUGHAN, Renata A. R.; MATTAR, Roberta A. M. P. F. Dini; LESSA, Maira; OLIVEIRA, Pedro S.; SILVA, Valquiria A.; GATTAZ, Wagner Farid; BRUNONI, Andre R.; FORLENZA, Orestes Vicente
    Introduction: Transcranial magnetic stimulation (TMS) is a consolidated procedure for the treatment of depression, with several meta-analyses demonstrating its efficacy. Theta-burst stimulation (TBS) is a modification of TMS with similar efficacy and shorter session duration. The geriatric population has many comorbidities and a high prevalence of depression, but few clinical trials are conducted specifically for this age group. TBS could be an option in this population, offering the advantages of few side effects and no pharmacological interactions. Therefore, our aim is to investigate the efficacy of TBS in geriatric depression.
  • article 5 Citação(ões) na Scopus
    White matter microstructure associated with anhedonia among individuals with bipolar disorders and high-risk for bipolar disorders
    (2022) DIAZ, Alexandre Paim; FERNANDES, Brisa S.; TEIXEIRA, Antonio Lucio; MWANGI, Benson; HASAN, Khader M.; WU, Mon-Ju; SELVARAJ, Sudhakar; SUEN, Paulo; ZANAO, Tamires Araujo; BRUNONI, Andre R.; SANCHES, Marsal; SOARES, Jair C.
    Background: Anhedonia - a key symptom of depression - is highly associated with poorer outcomes and suicidal behavior. Alterations in the circuitry of reward-related brain regions have been robustly associated with anhedonia in unipolar depression, but not bipolar disorder (BD). We investigated white matter microstructures associated with anhedonia in participants with BD types I and II and first-degree relatives of patients with BD (BD-siblings). Methods: Eighty participants (BD types I and II: 56 [70%], and BD-siblings: 24 [30%]) underwent diffusion tensor imaging (DTI); Fractional anisotropy (FA) of different tracts were computed. Anhedonia was assessed using item 8, (""inability to feel"") of the MADRS scale. General linear models were used to compare the FA of different tracts in participants with and without anhedonia controlling for several clinical and demographic variables. Results: The mean age of the sample was 37 (+/- 11) years old, and 68.8% were female. Participants with anhedonia (32.5%) presented lower mean FA in the left uncinate fasciculus (UF) (p = 0.005), right temporal endings of the superior longitudinal fasciculus (SLFT) (p = 0.04), and in the left and right parietal endings of the superior longitudinal fasciculus (SLFP) (p = 0.003, and p = 0.04, respectively). Similar comparisons between participants with or without current depressive episodes and between participants with or without inner tension according to the MADRS did not show significant differences, specificity of the findings for anhedonia. Conclusions: Lower FA in the left UF and SLF are potential neuroimaging markers of anhedonia in individuals with BD and high-risk for BD.
  • article 28 Citação(ões) na Scopus
    Prevalence and risk factors of psychiatric symptoms and diagnoses before and during the COVID-19 pandemic: findings from the ELSA-Brasil COVID-19 mental health cohort
    (2023) BRUNONI, Andre Russowsky; SUEN, Paulo Jeng Chian; BACCHI, Pedro Starzynski; RAZZA, Lais Boralli; KLEIN, Izio; SANTOS, Leonardo Afonso dos; SANTOS, Itamar de Souza; VALIENGO, Leandro da Costa Lane; GALLUCCI-NETO, Jose; MORENO, Marina Lopes; PINTO, Bianca Silva; FELIX, Larissa de Cassia Silva; SOUSA, Juliana Pereira de; VIANA, Maria Carmen; FORTE, Pamela Marques; CARDOSO, Marcia Cristina de Altisent Oliveira; BITTENCOURT, Marcio Sommer; PELOSOF, Rebeca; SIQUEIRA, Luciana Lima de; FATORI, Daniel; BELLINI, Helena; BUENO, Priscila Vilela Silveira; PASSOS, Ives Cavalcante; NUNES, Maria Angelica; SALUM, Giovanni Abrahao; BAUERMEISTER, Sarah; SMOLLER, Jordan W.; LOTUFO, Paulo Andrade; BENSENOR, Isabela Martins
    Background There is mixed evidence on increasing rates of psychiatric disorders and symptoms during the coronavirus disease 2019 (COVID-19) pandemic in 2020. We evaluated pandemic-related psychopathology and psychiatry diagnoses and their determinants in the Brazilian Longitudinal Study of Health (ELSA-Brasil) Sao Paulo Research Center. Methods Between pre-pandemic ELSA-Brasil assessments in 2008-2010 (wave-1), 2012-2014 (wave-2), 2016-2018 (wave-3) and three pandemic assessments in 2020 (COVID-19 waves in May-July, July-September, and October-December), rates of common psychiatric symptoms, and depressive, anxiety, and common mental disorders (CMDs) were compared using the Clinical Interview Scheduled-Revised (CIS-R) and the Depression Anxiety Stress Scale-21 (DASS-21). Multivariable generalized linear models, adjusted by age, gender, educational level, and ethnicity identified variables associated with an elevated risk for mental disorders. Results In 2117 participants (mean age 62.3 years, 58.2% females), rates of CMDs and depressive disorders did not significantly change over time, oscillating from 23.5% to 21.1%, and 3.3% to 2.8%, respectively; whereas rate of anxiety disorders significantly decreased (2008-2010: 13.8%; 2016-2018: 9.8%; 2020: 8%). There was a decrease along three wave-COVID assessments for depression [beta = -0.37, 99.5% confidence interval (CI) -0.50 to -0.23], anxiety (beta = -0.37, 99.5% CI -0.48 to -0.26), and stress (beta = -0.48, 99.5% CI -0.64 to -0.33) symptoms (all ps < 0.001). Younger age, female sex, lower educational level, non-white ethnicity, and previous psychiatric disorders were associated with increased odds for psychiatric disorders, whereas self-evaluated good health and good quality of relationships with decreased risk. Conclusion No consistent evidence of pandemic-related worsening psychopathology in our cohort was found. Indeed, psychiatric symptoms slightly decreased along 2020. Risk factors representing socioeconomic disadvantages were associated with increased odds of psychiatric disorders.
  • article 9 Citação(ões) na Scopus
    Examining the impact of the COVID-19 pandemic through the lens of the network approach to psychopathology: Analysis of the Brazilian Longitudinal Study of Health (ELSA-Brasil) cohort over a 12-year timespan
    (2022) SUEN, P. J. C.; BACCHI, P. S.; RAZZA, L.; SANTOS, L. A. dos; FATORI, D.; KLEIN, I.; PASSOS, I. C.; SMOLLER, J. W.; BAUERMEISTER, S.; GOULART, A. C.; SANTOS, I. de Souza; BENSENOR, I. M.; LOTUFO, P. A.; HEEREN, A.; BRUNONI, A. R.
    Cohort studies have displayed mixed findings on changes in mental symptoms severity in 2020, when the COVID-19 pandemic outbreak started. Network approaches can provide additional insights by analyzing the connectivity of such symptoms. We assessed the network structure of mental symptoms in the Brazilian Longitudinal Study of Health (ELSA-Brasil) in 3 waves: 2008–2010, 2017–2019, and 2020, and hypothesized that the 2020 network would present connectivity changes. We used the Clinical Interview Scheduled-Revised (CIS-R) questionnaire to evaluates the severity of 14 common mental symptoms. Networks were graphed using unregularized Gaussian models and compared using centrality and connectivity measures. The predictive power of centrality measures and individual symptoms were also estimated. Among 2011 participants (mean age: 62.1 years, 58% females), the pandemic symptom 2020 network displayed higher overall connectivity, especially among symptoms that were related to general worries, with increased local connectivity between general worries and worries about health, as well as between anxiety and phobia symptoms. There was no difference between 2008 and 2010 and 2017–2019 networks. According to the network theory of mental disorders, external factors could explain why the network structure became more densely connected in 2020 compared to previous observations. We speculate that the COVID-19 pandemic and its innumerous social, economical, and political consequences were prominent external factors driving such changes; although further assessments are warranted. © 2021 Elsevier Ltd